Includes specialty programs: Adolescent and Young Adult Cancer Program / Brain Tumor Program / Cancer Survivorship Program / Hemostasis and Thrombosis Center / Biorepository and Targeted Therapy Program / Sickle Cell Program / Stem Cell Transplant Program
Our specially trained and certified oncology staff treats a variety of pediatric cancers and offers a broad range of expertise in cancer and bleeding disorders. Studies have shown that the survival rates for infants, children, teens and young adults treated at a pediatric cancer center are greater than those at an adult hospital.
Our team includes board-certified pediatric hematologists-oncologists, advanced practice nurses, physician assistants, certified pediatric oncology nurses, pharmacists, clinical research associates, child life specialists, social workers, psychologists and educators. We also work closely with other specialty departments as needed, including surgery, pathology, radiology, pain management, nutrition, adolescent medicine, physical therapy, palliative care and genetics.
On average, we care for 8 newly-diagnosed children with cancer each month. The most common types of cancer are leukemia, brain and central nervous system cancers.
We are also active in national clinical trials for childhood cancer and blood disorders and explore the causes and treatment of these diseases through our basic science research program.
As a member of Children’s Oncology Group (COG), we participate in the development of National Cancer Institute-approved treatment protocols and offer the most up-to-date cancer therapies. Our program is one of only about a dozen pediatric cancer programs in the country verified by the American College of Surgeons Commission on Cancer.
As a major teaching institution affiliated with Northeast Ohio Medical University, we also train future doctors who want to specialize in pediatric hematology-oncology through our accredited fellowship training program.
For children and teens with high-risk tumors or cancers that have been unresponsive to standard treatment options, we offer individualized therapies through our Shannon E. Wilkes Targeted Therapy Program. This form of medicine uses information about the genetic make-up of a patient's cancer to identify drugs or other treatments that block the growth and spread of cancer.
Targeted therapies are typically less harmful to normal cells than standard chemotherapy.
National leader in improving quality and safety in Hematology-Oncology
In 2023, the Showers Family Center served patients from 40 counties in Ohio and 9 other states
Make a donation to support the Showers Family Center for Childhood Cancer and Blood Disorders
Director, Division of Hematology-Oncology; Pediatric Hematologist-Oncologist; LOPen Charities and Mawaka Family Chair in Pediatric Hematology/Oncology; Vice President, American Society of Pediatric Hematology/ Oncology 2023-2024
Pediatric Hematologist-Oncologist; Director, Quality Improvement, Hematology-Oncology; Co-Director, Resident Quality Improvement Initiative; Core Faculty of Hematology-Oncology; Pediatric Hematologist-Oncologist
Director, Divisional Research, Shannon E. Wilkes Targeted Therapy Program; The Jeffrey A. Barbour Chair for Pediatric Hematology/Oncology Research and Healing; Pediatric Hematologist-Oncologist
Vice President, Informatics; Chief Medical Information Officer; Pediatric Neuro-Oncologist; Marci M. Matthews Endowed Chair in Telehealth
Hematopoietic Stem Cell Transplantation Program Director; Pediatric Hematologist-Oncologist
Director, Childhood Cancer Survivorship Program and Pediatric Hematology-Oncology Fellowship Program; Pediatric Hematologist-Oncologist
Director, Neuro-Oncology; Director, Shannon E. Wilkes Targeted Therapy Program; Co-Director, Neurofibromatosis Clinic; Pediatric Neuro-Oncologist
Stem Cell Transplant Program Coordinator; Pediatric Nurse Practitioner; Co-Lead Hematology/Oncology Advance Practice Providers
Pediatric Nurse Practitioner; Co-Lead Hematology/Oncology Advance Practice Providers
For complete study information, please view the study on clinicaltrials.gov.
More about this study...For complete study information, please view the study on clinicaltrials.gov
More about this study...For complete study information, please view the study on clinicaltrials.gov
More about this study...For complete information, please view the project on clinicaltrials.gov
More about this study...For complete information, please visit the study on clinicaltrials.gov
More about this study...For complete details, please view the study on clinicaltrials.gov.
Study in conjunction with Cincinnati Children's Hospital.
More about this study...For complete information, please visit the study on clinicaltrials.gov
More about this study...For complete study details, please visit the study on clinicaltrials.gov.
More about this study...View complete study details here.
More about this study...For complete information, please visit the study at clinicaltrials.gov.
More about this study...Please view the study at clinicaltrials.gov for complete details.
More about this study...For complete information, please visit the study at Clinicaltrials.gov.
More about this study...Akron Children’s offers many resources to support for our cancer patients and their loved ones, not only while going through treatment but ongoing.
The Commission on Cancer (CoC), a quality program of the American College of Surgeons (ACS) has granted three-year accreditation to the cancer program at Akron Children's. To earn voluntary CoC accreditation, a cancer program must meet 34 CoC quality care standards, be evaluated every three years through a survey process, and maintain levels of excellence in the delivery of comprehensive patient-centered care.
ALL, AML, astrocytoma, bone cancer, bone and soft tissue tumors, brain and spinal cord tumors, cancer, craniopharyngiomas, ependymoma, Ewing sarcoma, germ cell tumors, glioma, Hodgkin's lymphoma, kidney tumors, leukemia, liver tumors, lymphoma, medulloblastoma, melanoma, neuroblastoma, neutropenia, oligodendrogliomas, osteosarcoma, pineoblastomas, retinoblastoma, rhabdomyosarcoma, thyroid masses, tumor, aplastic anemia, bleeding disorder, blood disorders, G6PD deficiency, hemophilia, hereditary hemorrhagic telangiectasia, idiopathic thrombocytopenic purpura, ITP, iron-deficiency anemia, severe combined immunodeficiency, sickle cell anemia, thalassemia, von Willebrand disease
By using this site, you consent to our use of cookies. To learn more, read our privacy policy.